Abstract
It is currently widely accepted that immune activation in HIV-infected individuals leads to a severe loss of CD4+ T cells and the progression to AIDS. However, the underlying mechanism of this immune activation remains unclear. Experimental data suggest that the activation of plasmacytoid dendritic cells (pDCs) by plasma viremia may play a critical role in HIV-induced immune activation. In this study, we found that the level of immune activation was higher in the late phase of SIVmac239 infection compared with chronic infection, which suggests that immune activation might be related to disease progression in SIVmac239-infected non-human primate models. Our work also showed that chloroquine could effectively inhibit the activation of pDCs in vitro and in vivo. However, chloroquine treatment of SIVmac239-infected macaques had no significant influence on the Cellular composition of peripheral blood in these animals.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ketloy C, Engering A, Srichairatanakul U, Limsalakpetch A, Yongvanitchit K, Pichyangkul S et al. Expression and function of Toll-like receptors on dendritic cells and other antigen presenting cells from non-human primates. Vet Immunol Immunopathol 2008; 125: 18–30.
John L, Lutwama F . A review of the use of activation markers in Africa. J HIV Ther 2010; 15: 11–14.
Mir KD, Gasper MA, Sundaravaradan V, Sodora DL . SIV infection in natural hosts: resolution of immune activation during the acute-to-chronic transition phase. Microbes Infect 2011; 13: 14–24.
Deeks SG, Kitchen CM, Liu L, Guo H, Gascon R, Narváez AB et al. Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood 2004; 104: 942–947.
Hazenberg MD, Otto SA, van Benthem BH, Roos MT, Coutinho RA, Lange JM et al. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 2003; 17: 1881–1888.
Kovacs A, Karim R, Mack WJ, Xu J, Chen Z, Operskalski E et al. Activation of CD8 T cells predicts progression of HIV infection in women coinfected with hepatitis C virus. J Infect Dis 2010; 201: 823–834.
Chang JJ, Altfeld M . Innate immune activation in primary HIV-1 infection. J Infect Dis 2010; 202 ( Suppl 2): S297–S301.
Savarino A, Boelaert JR, Cassone A, Majori G, Cauda R . Effects of chloroquine on viral infections: an old drug against today's diseases? Lancet Infect Dis 2003; 11: 722–727.
Martinson JA, Montoya CJ, Usuga X, Ronquillo R, Landay AL, Desai SN . Chloroquine modulates HIV-1-induced plasmacytoid dendritic cell alpha interferon: implication for T-cell activation. Antimicrob Agents Chemother 2010; 54: 871–881.
Beignon AS, McKenna K, Skoberne M, Manches O, DaSilva I, Kavanagh DG et al. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J Clin Invest 2005; 11: 3265–3275.
Murray SM, Down CM, Boulware DR, Stauffer WM, Cavert WP, Schacker TW et al. Reduction of immune activation with chloroquine therapy during chronic HIV infection. J Virol 2010; 22: 12082–12086.
Piconi S, Parisotto S, Rizzardini G, Passerini S, Terzi R, Argenteri B et al. Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy-treated immunologic nonresponders. Blood 2011; 12: 3263–3272.
Xia HJ, Zhang GH, Ma JP, Dai ZX, Li SY, Han JB et al. Dendritic cell subsets dynamics and cytokine production in SIVmac239-infected Chinese rhesus macaques. Retrovirology 2010; 7: 102.
Xia HJ, Zhang GH, Wang RR, Zheng YT . The influence of age and sex on the cell counts of peripheral blood leukocyte subpopulations in Chinese rhesus macaques. Cell Mol Immunol 2009; 6: 433–440.
Lane HC, Masur H, Edgar LC, Whalen G, Rook AH, Fauci AS . Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med 1983; 309: 453–458 .
Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S et al. Microbial translocation is a cause of systemic immune. Nat Med 2006; 12: 1365–1371.
Said EA, Dupuy FP, Trautmann L, Zhang Y, Shi Y, El-Far M et al. Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection. Nat Med 2010; 16: 452–459.
Colonna M, Trinchieri G, Liu YJ . Plasmacytoid dendritic cells in immunity. Nat Immunol 2004; 5: 1219–1226.
Zhang Z, Wang FS . Plasmacytoid dendritic cells act as the most competent cell type in linking antiviral innate and adaptive immune responses. Cell Mol Immunol 2005; 6: 411–417.
Fitzgerald-Bocarsly P, Dai J, Singh S . Plasmacytoid dendritic cells and type I IFN: 50 year of convergent history. Cytokine Growth Factor Rev 2008; 19: 3–19.
Iwasaki A, Medzhitov R . Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004; 5: 987–995.
Xia HJ, Ma JP, Zhang GH, Han JB, Wang JH, Zheng YT . Effect of plasma viremia on apoptosis and immunophenotype of dendritic cells subsets in acute SIVmac239 infection of Chinese rhesus macaques. PLoS ONE 2011; 6: e29036.
Herbeuval JP, Shearer GM . HIV-1 immunopathogenesis: how good interferon turns bad. Clin Immunol 2007; 123: 121–128.
Meier A, Chang JJ, Chan ES, Pollard RB, Sidhu HK, Kulkarni S et al. Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1. Nat Med 2009; 8: 955–959.
Lehmann C, Harper JM, Taubert D, Hartmann P, Fätkenheuer G, Jung N et al. Increased interferon alpha expression in circulating plasmacytoid dendritic cells of HIV-1-infected patients. J Acquir Immune Defic Syndr 2008; 48: 522–530.
Baenziger S, Heikenwalder M, Johansen P, Schlaepfer E, Hofer U, Miller RC et al. Triggering TLR7 in mice induces immune activation and lymphoid system disruption, resembling HIV-mediated pathology. Blood 2009; 113: 377–388.
Jacquelin B, Mayau V, Targat B, Liovat AS, Kunkel D, Petitjean G et al. Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response. J Clin Invest 2009; 12: 3544–3555.
Acknowledgements
This work was supported in part by grants from the National Basic Research Program of China (2009CB522306 and 2012CBA01305), the National Natural Science Foundation of China (30872317, 30800113, U0832601 and 81172876), the Knowledge Innovation Program of CAS (KSCX1-YW-10 and KSCX2-EW-R-13), the Key Scientific and Technological Program of China (2009ZX09501-029, 2012ZX10001-006 and 2012ZX10001-007) and Yunnan province (2010GA001) and the ‘Western Light’ Projects of the CAS. The funding organizations had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ma, JP., Xia, HJ., Zhang, GH. et al. Inhibitory effects of chloroquine on the activation of plasmacytoid dendritic cells in SIVmac239-infected Chinese rhesus macaques. Cell Mol Immunol 9, 410–416 (2012). https://doi.org/10.1038/cmi.2012.22
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/cmi.2012.22
Keywords
This article is cited by
-
Accelerated disease progression and robust innate host response in aged SIVmac239-infected Chinese rhesus macaques is associated with enhanced immunosenescence
Scientific Reports (2017)
-
Chloroquine inhibits human CD4+ T-cell activation by AP-1 signaling modulation
Scientific Reports (2017)
-
Chloroquine and beyond: exploring anti-rheumatic drugs to reduce immune hyperactivation in HIV/AIDS
Retrovirology (2015)